At AstraZeneca we share a common purpose: to push the boundaries of science to deliver life-changing medicines.

Innovation needs the right environment to flourish

We conduct our research across three continents, manufacture in 16 countries and work in over 100 countries.


Cambridge, UK

Our new facility in Cambridge will bring together our small molecule and biologics research and development activity. It will be our largest centre for oncology research, as well as cardiovascular and metabolic diseases, respiratory, inflammation and autoimmune diseases and conditions of the central nervous system.


Gothenburg, Sweden

Our Mölndal Strategic R&D centre, just south of Gothenburg, offers a vibrant workspace where research-led ideas can be turned into innovative new medicines and collaborating to stimulate creative scientific thinking is key to delivering our vision.


Gaithersburg, USA

Gaithersburg, MD is home to MedImmune headquarters and is AstraZeneca’s primary location for biologics R&D activities in the US. It is also the location of AstraZeneca’s Specialty Products Group.